0
edits
mNo edit summary |
|||
Line 191: | Line 191: | ||
|- | |- | ||
| style="padding-left:12px" | < | | style="padding-left:12px" | <font color="blue">LV diastolic volume/BSA, mL/m<sup>2</sup></font> | ||
| align="center" | | | align="center" | 35–75 | ||
| align="center" | | | align="center" | 76–86 | ||
| align="center" | | | align="center" | 87–96 | ||
| align="center" | < | | align="center" | <font color="blue">≥97</font> | ||
| align="center" | | | align="center" | 35–75 | ||
| align="center" | | | align="center" | 76–86 | ||
| align="center" | | | align="center" | 87–96 | ||
| align="center" | < | | align="center" | <font color="blue">≥97</font> | ||
|- | |- | ||
Line 213: | Line 213: | ||
|- | |- | ||
| style="padding-left:12px" | < | | style="padding-left:12px" | <font color="blue">LV systolic volume/BSA, mL/m<sup>2</sup></font> | ||
| align="center" | | | align="center" | 12–30 | ||
| align="center" | | | align="center" | 31–36 | ||
| align="center" | | | align="center" | 37–42 | ||
| align="center" | < | | align="center" | <font color="blue">≥43</font> | ||
| align="center" | | | align="center" | 12–30 | ||
| align="center" | | | align="center" | 31–36 | ||
| align="center" | | | align="center" | 37–42 | ||
| align="center" | < | | align="center" | <font color="blue">≥43</font> | ||
|- | |- | ||
| colspan="9" | <ul> | | colspan="9" | <ul> | ||
<li | <li>BSA, body surface area; LV, left ventricular.</li> | ||
<li> | <li>Blue values: Recommended and best validated.</li> | ||
</ul> | </ul> | ||
|} | |} | ||
Line 277: | Line 277: | ||
|- | |- | ||
| style="padding-left:12px" | | | style="padding-left:12px" | Ejection fraction, % | ||
| align="center" | ≥ | | align="center" | ≥55 | ||
| align="center" | | | align="center" | 45–54 | ||
| align="center" | | | align="center" | 30–44 | ||
| align="center" | < | | align="center" | <30 | ||
| align="center" | ≥ | | align="center" | ≥55 | ||
| align="center" | | | align="center" | 45–54 | ||
| align="center" | | | align="center" | 30–44 | ||
| align="center" | < | | align="center" | <30 | ||
|- | |- | ||
| colspan="9" | <ul> | | colspan="9" | <ul> | ||
<li>2D, Two-dimensional.</li> | <li>2D, Two-dimensional.</li> | ||
<li> | <li>Blue values: Recommended and best validated.</li> | ||
</ul> | </ul> | ||
Line 359: | Line 359: | ||
|- | |- | ||
| colspan="5" | <ul><li | | colspan="5" | <ul><li>RV, Right ventricular; RVOT, right ventricular outflow tract; PA, pulmonary artery.</li> | ||
<li>Data from Foale et al.<cite>Foale</cite></li></ul> | <li>Data from Foale et al.<cite>Foale</cite></li></ul> | ||
Line 399: | Line 399: | ||
| colspan="4" | | | colspan="4" | | ||
<ul> | <ul> | ||
<li | <li>RV, Right ventricular.</li> | ||
<li>Data from Weyman.<cite>Weyman</cite></li> | <li>Data from Weyman.<cite>Weyman</cite></li> | ||
</ul> | </ul> | ||
Line 501: | Line 501: | ||
|- | |- | ||
| < | | <font color="blue">LA volume/BSA, mL/m2</font> | ||
| align="center" | | | align="center" | 22 ± 6 | ||
| align="center" | | | align="center" | 29–33 | ||
| align="center" | | | align="center" | 34–39 | ||
| align="center" | < | | align="center" | <font color="blue">≥40</font> | ||
| align="center" | | | align="center" | 22 ± 6 | ||
| align="center" | | | align="center" | 29–33 | ||
| align="center" | | | align="center" | 34–39 | ||
| align="center" | <font color="blue"> 40</font> | | align="center" | <font color="blue"> 40</font> | ||
|- | |- | ||
| colspan="9" | | | colspan="9" | | ||
<ul> | <ul> | ||
<li | <li>BSA, Body surface area; LA, left atrial; RA, right atrial.</li> | ||
<li> | <li>Blue values: Recommended and best validated.</li> | ||
</ul> | </ul> | ||
edits